Contractor intelligence · computed from public award records
FPI
- Awards won
- 30
- Known value
- USD 3.0M
- First award
- 11 Nov 2018
- Most recent
- 22 Jul 2019
Wins by funder
| Funder | Awards | Known value | Most recent |
|---|---|---|---|
| World Bank | 30 | USD 3.0M | 22 Jul 2019 |
Where the work is
EG · 30
Sources
The most recent award records behind the figures above. Every number on this page is computed from records like these — nothing is estimated or editorial.
- Procurement of hepatitis C drugs · 22 Jul 2019 · USD 108K · World Bank
- Purchase of hepatitis c drugs · 22 Jul 2019 · USD 107K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 22 Jul 2019 · USD 107K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 22 Jul 2019 · USD 106K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 22 Jul 2019 · USD 107K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 22 Jul 2019 · USD 106K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 24 Mar 2019 · USD 106K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 24 Mar 2019 · USD 106K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 24 Mar 2019 · USD 106K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 24 Mar 2019 · USD 106K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 24 Mar 2019 · USD 106K · World Bank
- procurement of virus C drugs (Sofosbuvir 400mg ,Daclatasvir 60 mg) · 24 Mar 2019 · USD 105K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 24 Mar 2019 · USD 106K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 24 Mar 2019 · USD 106K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 31 Dec 2018 · USD 59K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 25 Dec 2018 · USD 98K · World Bank
- Sofosbuvir 400mg+ Daclatasvir 60 mg · 11 Nov 2018 · USD 95K · World Bank
- all technical offers are accepted for The Sofosbuvir 400mg , Daclatasvir 60 mg drugs · 11 Nov 2018 · USD 96K · World Bank
- The Sofosbuvir 400mg , Daclatasvir 60 mg drugs were awarded to FPI co as the offers are technically acceptable and the lowest offered prices · 11 Nov 2018 · USD 95K · World Bank
- The drugs were awarded to FPI Co. as the offers are technically acceptable and the lowest offered prices · 11 Nov 2018 · USD 95K · World Bank
Method
Computed from 30 award records ingested from official disclosure sources (World Bank, Inter-American Development Bank, and published contract-award notices). Values are shown in USD where the source published one; entity identity is resolved conservatively and reviewed. GLODA is not affiliated with any funder or contractor shown. Last computed 15 Sept 2026.